Paper923960
Is porphobilinogen deaminase activity a secondary control mechanism in haem biosynthesis in humans? [proceedings].
Brodie MJ and 4 others. Biochem Soc Trans, 1977. Cited by 31 papers, by iCite.
Cite this record
ConductScience Library. Is porphobilinogen deaminase activity a secondary control mechanism in haem biosynthesis in humans? [proceedings]. Papers, record 923960. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/923960
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Is porphobilinogen deaminase activity a secondary control mechanism in haem biosynthesis in humans? [proceedings].
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ammonia-Lyases | Major topic |
| Heme | Major topic |
| Hydroxymethylbilane Synthase | Major topic |
| 5-Aminolevulinate Synthetase | |
| Erythrocytes | |
| Humans | |
| Lead Poisoning | |
| Leukocytes | |
| Porphyrias |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 16660874 | Disappearance of porphobilinogen deaminase activity in leaves before the onset of senescence. | Plant Physiol | 1979 | https://conductscience.org/library/papers/16660874 | PubMed |
| 15793285 | Hepatic gene expression in protoporphyic Fech mice is associated with cholestatic injury but not a marked depletion of the heme regulatory pool. | Am J Pathol | 2005 | https://conductscience.org/library/papers/15793285 | PubMed |
| 12962144 | Correction of the biochemical defect in porphobilinogen deaminase deficient cells by non-viral gene delivery. | Mol Cell Biochem | 2003 | https://conductscience.org/library/papers/12962144 | PubMed |
| 7682572 | Allosteric inhibition of human lymphoblast and purified porphobilinogen deaminase by protoporphyrinogen and coproporphyrinogen. A possible mechanism for the acute attack of variegate porphyria. | J Clin Invest | 1993 | https://conductscience.org/library/papers/7682572 | PubMed |
| 7326026 | Conversion of 5-aminolaevulinate into haem by liver homogenates. Comparison of rat and chick embryo. | Biochem J | 1981 | https://conductscience.org/library/papers/7326026 | PubMed |
| 4004804 | Conversion of 5-aminolaevulinate into haem by homogenates of human liver. Comparison with rat and chick-embryo liver homogenates. | Biochem J | 1985 | https://conductscience.org/library/papers/4004804 | PubMed |
| 3567053 | Antipyrine metabolism in acute hepatic porphyria in relapse and remission. | Br J Clin Pharmacol | 1987 | https://conductscience.org/library/papers/3567053 | PubMed |
| 42911 | Uroporphyrinogen I synthase from human erythrocytes: separation, purification, and properties of isoenzymes. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/42911 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| HMBS | 3145 | PubTator's text mining | https://conductscience.org/library/genes/3145 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/923960
GET https://conductscience.org/api/papers/v1/923960/authors